FDA Inspection 863798 — Anacor Pharmaceuticals
The FDA completed an inspection of Anacor Pharmaceuticals on January 29, 2014 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 29, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Palo Alto, CA (United States)
Additional Details
Sponsor, Contract Research Organization